Navigation Links
Marco Romano, MD Joins Chiltern as Medical Director, Europe

LONDON, Oct. 3 /PRNewswire/ -- Chiltern, a leading global clinical research organization, has announced the appointment of Marco Romano, MD to the role of Medical Director, Europe. Dr. Romano has over 19 years of experience in both the Pharmaceutical and CRO Industries where he held executive-level positions, most recently with a large USA based CRO.

Dr. Romano earned his MD at the University of Genova, Italy, and he also holds a post-graduate degree in Hygiene, Epidemiology and Public Health from the University of Genova and a post-graduate degree in Clinical Pharmacology from the University of Milan. Dr Romano co-authored several scientific papers on mutagenesis and cancerogenesis, pharmacokinetics and pharmacodynamics of chemical compounds and glutathione metabolism.

Dr. Romano will be located in the company's Milan office. He will be responsible for the European medical department as well as heading one of our Global Therapeutic Area Teams. Dr. Romano will also focus on providing medical and scientific expertise to sponsors regarding product development and product life cycle management strategies. Dr Romano is closely connected to the Italian Pharmaceutical sector and will soon be President of SSFA, an influential medical association in Italy. His extensive experience and network will lead to the further development of our Italian operations.

"I am very pleased to join Chiltern," said Marco. "The global medical team is very strong and I look forward to working with them, our sponsors and our therapeutic focused teams."

"I am delighted that Marco has joined Chiltern," commented Lewis Cameron, Executive Vice President, Europe. "Marco's strong industry background and overall in-depth experience in clinical research will add to the dedicated medical and therapeutic teams already in place."

About Chiltern:

Established in 1982, Chiltern is a leading global Contract Research Organization with extensive experience of running and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 1000 people with 18 offices across the United States, Europe and in India. Chiltern provides services including Early Phase, Global Clinical Development, Late Phase, Biometrics, Medical and Regulatory Affairs and Resourcing Solutions.

For More Information Contact:

Catherine Lemercier

Chiltern International, Inc.

2111 Palomar Airport Road

Suite 200


CA 92011


Tel: 1 (760) 707 5025

Fax: 1 (760) 707 5022


Richard Baptista

Chiltern International Ltd.

171 Bath Road





Tel: 44 (0) 1753 512 000

Fax: 44 (0) 1753 511 116


Chiltern: Understanding

SOURCE Chiltern
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Ranbaxy joins hand with Cipla to co-market ciprofloxacin
2. Rat joins list of cloned animals
3. Richard Gere Joins Indian Stars For Fight Against AIDS
4. Enbrel Joins with Methotrexate to Cure Rheumatoid Arthritis
5. Anoushka Joins Hands With WFP to Feed the Poor
6. India Joins Hands With Global Body for Vaccine Research
7. Another Statewide Organization Joins the Fight Against Assisted Suicide
8. Two-year-old Joins Mensa, Becomes Its Youngest Ever Genius
9. Check if your “Favourite medical web-site” is indulging in Quackey
10. Teens turning to Internet for medical queries
11. Robots craft medical history
Post Your Comments:
(Date:6/27/2016)... ... 27, 2016 , ... TherapySites, the leading website ... Tennessee Counseling Association. This new relationship allows TherapySites to continue to ... adding exclusive benefits and promotional offers. , "TCA is extremely excited about this ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... recently ... of Eyeglasses . , Millions of individuals in the United States and Canada ... become a way to both correct vision and make a fashion statement. Even celebrities ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Bracket , a leading clinical trial technology and ... platform, Bracket eCOA (SM) 6.0, at the 52 nd ... 2016 in Philadelphia , Pennsylvania.  A demonstration ... of its kind to fully integrate with RTSM, will be ... is a flexible platform for electronic clinical outcomes assessments that ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
(Date:6/23/2016)... 2016 The vast majority of dialysis patients ... Treatments are usually 3 times a week, with treatment ... travel time, equipment preparation and wait time.  This regimen ... for patients who are elderly and frail.  Many elderly ... rehabilitation centers for some duration of time. ...
Breaking Medicine Technology: